Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosis

Infection

Volumn 34, Issue 6, 2006, Pages 342-344

  Woessner, R ^a   Grauer, M T ^b   Frese, A ^c   Bethke, F ^d   Ginger, T ^a   Hans, A ^e   Treib, J ^a  

^a Westpfalz Medical Center   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d Dept of Neurology   (Germany)

^e NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ROXITHROMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; EXPANDED DISABILITY STATUS SCALE; HUMAN; LONG TERM CARE; MULTIPLE SCLEROSIS; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; MULTIPLE SCLEROSIS; PILOT PROJECTS; ROXITHROMYCIN; TREATMENT FAILURE;

EID: 33845719953     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-006-5114-8     Document Type: Article

References (20)

1. Woessner R, Grauer MT, Haass A, Gaertner B, Holzer G, Mueller-Reiland D, Mueller-Lantzsch N, Treib J: Effects of multiple sclerosis and other inflammatory CNS disorders on tick-borne encephalitis (TBE) serology. Acta Virol 1999; 43: 331-333.
2. Sriram S, Mitchell W, Stratton C: Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS. Neurology 1998; 50: 571-572.
3. Sriram S, Stratton CW, Yao S, Tharp A, Ding L, Bannan JD, Mitchell WM: Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 1999; 46: 6-14.
4. Woessner R, Treib J: Chlamydia infections in neurology. Dtsch Med Wochenschr 2000; 126: 153-155.
5. Boman J, Roblin PM, Sundstrom P, Sandstrom M, Hammerschlag MR: Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Neurology 2000; 54: 265.
6. Furrows SJ, Hartley JC, Bell J, Silver N, Losseff N, Stevenson S, Chapman M, Thompson EJ, Ridgway GL, Giovannoni G: Chlamydophila pneumoniae infection of the central nervous system in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2004; 75: 152-154.
7. Ke Z, Lu F, Roblin P, Boman J, Hammerschlag MR, Kalman B: Lack of detectable Chlamydia pneumoniae in brain lesions of patients with multiple sclerosis. Ann Neurol 2000; 48: 400.
8. Morre SA, De Groot CJ, Killestein J, Meijer CJ, Polman CH, Van der Valk P, Van den Brule AJ: Is Chlamydia pneumoniae present in the central nervous system of multiple sclerosis patients? Ann Neurol 2000; 48: 399.
9. Pucci E, Taus C, Cartechini E, Morelli M, Giuliani C, Clementi M, Menzo S: Lack of Chlamydia infection of the central nervous system in multiple sclerosis. Ann Neurol 2000; 48: 399-400.
10. Saiz A, Marcos MA, Graus F, Vidal J, Jimenez de Anta MT: No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis. J Neurol 2001; 248: 617-618.
11. Treib J, Haass A, Stille W, Maass M, Stephan C, Holzer G, Morgenthaler M, Woessner R, Grauer MT: Multiple Sclerosis and Chlamydia pneumoniae. Ann Neurol 2000; 47: 408.
12. Sriram S, Stratton CW, Yao S: Reply. Ann Neurol 2000; 47: 409-410.
13. Layh-Schmitt G, Bendl C, Hildt U, Dong-Si T, Juttler E, Schnitzler P, Grond-Ginsbach C, Grau AJ: Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis. Ann Neurol 2000; 47: 652-655.
14. Gieffers J, Pohl D, Treib J, Dittmann R, Stephan C, Klotz K, Hanefeld F, Solbach W, Haass A, Maass M: Presence of Chlamydia pneumoniae DNA in the CSF is a common phenomen in a variety of neurological diseases and not restricted to multiple sclerosis. Ann Neurol 2001; 49: 585-589.
15. Buljevac D, Verkooyen RP, Jacobs BC, Hop W, van der Zwaan LA, van Doom PA, Hintzen RO: Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients. Ann Neurol 2003; 54: 828-831.
16. Yao SY, Stratton CW, Mitchell WM, Sriram S. CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology 2001; 56: 1168-1176.
17. Derfuss T, Gurkov R, Then Bergh F, Goebels N, Hartmann M, Barz C, Wilske B, Autenrieth I, Wick M, Hohlfeld R, Meinl E: Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain 2001; 124: 1325-1335.
18. Rostasy K, Reiber H, Pohl D, Lange P, Ohlenbusch A, Eiffert H, Maass M, Hanefeld F: Chlamydia pneumoniae in children with MS: frequency and quantity of intrathecal antibodies. Neurology. 2003; 61: 125-128.
19. Popovic N, Schubart A, Goetz BD, Zhang SC, Linington C, Duncan ID: Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 2002; 51: 215-223.
20. Nessler S, Dodel R, Bittner A, Reuss S, Du Y, Hemmer B, Sommer N: Effect of minocycline in experimental autoimmune encephalomyelitis. Ann Neurol 2002; 52: 689-690.